Peptide-guided cancer drugs show promise in mice.
Barinaga
M
M
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D004337:Drug Carriers; D006801:Humans; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000098:blood supply* / Q000188:drug therapy*; D009842:Oligopeptides / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D004337:Drug Carriers; D009842:Oligopeptides; C109962:doxorubicin cysteinyl-asparagyl-glycyl-arginyl-cysteine conjugate; C109961:doxorubucin cysteinyl-aspartyl-cysteinyl-arginyl-glycyl-aspartyl-cycsteinyl-phenylalanyl-cysteine conjugate; D004317:Doxorubicin